Article Versions Notes

Chi KN, Yip SM, Bauman G, Probst S, Emmenegger U, Kollmannsberger CK, Martineau P, Niazi T, Pouliot F, Rendon R, et al. ¹⁷⁷Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: A Review of the Evidence and Implications for Canadian Clinical Practice. Current Oncology. 2024; 31(3):1400-1415. https://doi.org/10.3390/curroncol31030106

Chi, Kim N., Steven M. Yip, Glenn Bauman, Stephan Probst, Urban Emmenegger, Christian K. Kollmannsberger, Patrick Martineau, Tamim Niazi, Frédéric Pouliot, Ricardo Rendon, and et al. 2024. "¹⁷⁷Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: A Review of the Evidence and Implications for Canadian Clinical Practice" Current Oncology 31, no. 3: 1400-1415. https://doi.org/10.3390/curroncol31030106

Chi, K. N., Yip, S. M., Bauman, G., Probst, S., Emmenegger, U., Kollmannsberger, C. K., Martineau, P., Niazi, T., Pouliot, F., Rendon, R., Hotte, S. J., Laidley, D. T., & Saad, F. (2024). ¹⁷⁷Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: A Review of the Evidence and Implications for Canadian Clinical Practice. Current Oncology, 31(3), 1400-1415. https://doi.org/10.3390/curroncol31030106